Dr. Jim Heath has joined a prestigious group of cancer researchers as a newly elected Fellow of the American Academy for Cancer Research (AACR) Academy Class of 2022.
The AACR Academy’s mission is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer.
Heath was chosen as an AACR Academy Fellow for his pivotal contributions to the fields of biotechnology and cancer immunotherapy, bridging chemical synthesis and physics with biology to develop nanoscale technologies including single cell barcoding, the isolation of T cells recognizing neoantigens to generate novel T-cell therapies, and microfluidic chips for diagnostic purposes that provide an opportunity to stratify patients and analyze a patient’s antitumor response to drug treatment.
Heath is one of 33 scientists elected for this year’s class of Fellows. The newly elected class joins 256 existing Fellows. Fellows of the AACR Academy serve as a global brain trust of top contributors to cancer science and medicine who help advance the mission of the AACR to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
